anaesthesia in ginecological laparoscopic interventions MedDRA version: 6.1 Level: PT Classification code 10021723
Conditions
Interventions
Trade Name: SUPRANE*LIQ INAL FL 240ML
Pharmaceutical Form: Inhalation vapour, liquid
INN or Proposed INN: Desflurane
Concentration unit: ml millilitre(s)
Concentration type: equal
Concentration number
Sponsors
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - female aged 18-45; - Body Mass Index between 18 and 25; - Patients affected by sterility and/or benign ovarian cysts; Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: cardiovascular, autoimmune, endocrynological diseases; - Body Mass Index > 25; - ASA > 2;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Evaluate the best inflammatory and neuroendocrine response.;Secondary Objective: Evaluate the outcome and the patient?s satisfaction.;Primary end point(s): best response in perioperative stress | — |
Countries
Italy
Outcome results
None listed